Sign in

CIK 0001622229 · Large accelerated filer

Cogent Biosciences, Inc.

Sign in to watch
Ticker
COGT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
465308248
Phone
617-945-5576
Business address
180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
Former names
Unum Therapeutics Inc., Unum Therapeutics, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy Chief Commercial Officer bought 43,750 shares at $7.60 ($332,413)
  7. 4 Derivatives Options or other derivatives
  8. 8-K Event Other events
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G/A Stake Amended Statement of Ownership
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. SC 13G/A Stake Amended Statement of Ownership
  17. SC 13G/A Stake Amended Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 8-K Event Other events
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 7 of 31 · 616 filings